NEW

Health Care Leaders Form Trustworthy & Responsible AI Network (TRAIN)

Monday, at the HIMSS 2024 Global Health Conference, a new consortium of healthcare leaders announced the creation of the Trustworthy & Responsible AI Network (TRAIN), which aims to operationalize responsible AI principles to improve the quality, safety and...

EPA Rule to Slash EtO Emissions, Reduce Cancer Risk

The U.S. Environmental Protection Agency has announced a rule that will reduce lifetime cancer risks for people living near commercial sterilization facilities across the country. The final amendments to the air toxics standards for ethylene oxide commercial...

AI Revolutionizes General Surgery, says GlobalData

Artificial intelligence (AI) integration in general surgery has surged, promising revolutionary advancements in precision and patient outcomes. AI tools have transformed preoperative planning, intraoperative assistance, and postoperative care, enhancing diagnostic...

Study Shows Potential for Using AI Tools to Detect Healthcare-Associated Infections

A new proof-of-concept study published today in the American Journal of Infection Control (AJIC) reports that artificial intelligence (AI) technologies can accurately identify cases of healthcare-associated infections (HAI) even in complex clinical scenarios. The...

Medtech Receives FDA Clearance for Rosa Spine

Medtech has received 510K clearance from the United States Food and Drug Administration to market the ROSA Spine robot in the U.S.

Obtaining FDA clearance is a major step in Medtech’s development strategy and will allow the company to market the ROSA Spine robot in the United States for minimally invasive surgical procedures on the spine. Around 3 million such procedures are performed world-wide each year.

“We are thrilled to have FDA approval for ROSA Spine,” Medtech CEO Bertin Nahum said. “Building on the success that ROSA Brain has encountered on the Ameri-can market, this new key regulatory milestone will allow us to strengthen our position in the world’s leading market for spine surgery. In addition, the FDA approval again refl ects our capacity to respect the commitments we made at the time of our IPO, growing as a company while offering innovative robotic technology.”

The ROSA platform was previously approved in the U.S. for brain surgery in 2012. There are currently 27 ROSA Brain systems installed in American facilities.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X